SAN FRANCISCO —The AREDS2 formulation and a Mediterranean diet, especially fish, can help reduce the risk for patient progression to advanced age-related macular degeneration, while advancements in deep learning capabilities can improve ophthalmic diagnostic capabilities, according to a speaker here.
“The AREDS2 formulation is recommended to patients with intermediate or late AMD, and genetic testing is encouraged for research purposes but not for clinical care yet. Deep learning may help us in the future for more accurate and more efficient clinical practice but won’t
Uncategorized